Issue 3, 2021

Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice

Abstract

Antibiotic therapy comes with disturbances on human microbiota, resulting in changes of bacterial communities and thus leading to well-established health problems. In this study, we demonstrated that targeted teicoplanin administration maintains the faecal microbiota composition undisturbed in a mouse model while reaching therapeutic improvements for S. aureus infection.

Graphical abstract: Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice

Supplementary files

Article information

Article type
Research Article
Submitted
09 Oct 2020
Accepted
13 Dec 2020
First published
15 Jan 2021

RSC Med. Chem., 2021,12, 380-383

Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice

B. A. Borsa, M. Sudagidan, M. E. Aldag, I. I. Baris, E. E. Acar, C. Acuner, M. Kavruk and V. C. Ozalp, RSC Med. Chem., 2021, 12, 380 DOI: 10.1039/D0MD00347F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements